LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).

Biotechnology

LegoChem Biosciences

Yong Zu Kim

Yun Hee Park

Sook Kyung Chang

KWANG HWA JUNG

Jae ook Kim, Ph.D.

Keon Woo Kwon

현진 배

Byeongjun Yu

YongSoo Yoon

YeongSoo Oh

Jaseong Koo

Chul-Woong Chung

Jeiwook Chae

Sejin Park

Young Lag Cho

Chang Sun Lee

The executive team at LegoChem Biosciences has a history of experience in the development of new drugs and research. The team's head of R&D has a background in developmental biology from the University of Virginia, and a postdoctoral fellowship from Harvard University. This experience gives the team the ability to develop new drugs and conduct research at a high level.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at LegoChem Biosciences

Leadership Team